Form D · Biotechnology
Satellite Biosciences, Inc.
Cambridge, MA · CIK 0001832180
Offering snapshot reported Mar 11, 2022 · SEC filing
- Reported sold
- $82.5M Offering amount: $100M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 25, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2022 | Initial | $82,470,989 | No comparison | 10 | SEC filing |
| Nov 17, 2020 | Initial | $19,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-436997
Source: Form D, filed Mar 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sujata Bhatia | Director |
| Sangeeta Bhatia | Promoter |
| Christopher Chen | Director, Promoter |
| Laura Lande Diner | Executive |
| David Lennon | Director, Executive |
| Thomas Lowery | Executive |
| Diane Marcou | Executive |
| Eileen Mc Guire | Director |
| Ellie Mc Guire | Director |
| Yair Schindel | Director |
| Ling Wong | Director |
| William Young | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
700 Main Street
Cambridge, MA, 02139
Cambridge, MA, 02139